Global Biosimilars Market Forecast to 2015

Global Biosimilars Market Forecast to 2015


March 1, 2012
140 Pages - SKU: CICQ3805832
License type:
Online Download      US $1,500.00
CD-ROM Mail Delivery      US $1,700.00
Global Site License      US $2,200.00
Hard Copy Mail Delivery      US $1,700.00
Countries covered: Global

The biosimilars industry has been growing stupendously across the globe for past few years. Increasing healthcare costs and rising aging population are driving the industry, which stands at a vivid position and is expected to evolve greatly from its current state. As per the estimations of our latest report, the global biosimilars market will grow at a CAGR of around 52% during 2010-2015. With the governments and private players worldwide stepping in the industry, the market shows bright prospects and immense opportunities to cash in on.

According to “Global Biosimilars Market Forecast to 2015”, the first-generation biosimilars currently dominate the market, and their second-generation is expected to grow stupendously in the future. Our report provides a thorough study of the biosimilars market, and its segmentation at the product and country level. We have carried out a detailed market-segmentation analysis in the study, which presents forecasts on the first-generation biosimilars. Key developments in each segment have also been highlighted in it to tell ‘what is going on’ in the market.

For key regulated and unregulated markets including the US, Europe, India, China and Korea, the geographic-segmentation has been included. Our research has studied the overall industry performance and key biosimilar products in the market, and found that patent expirations offer a huge potential to new market entrants. The recent industry activities have been tracked, and the regulatory scenario has been analyzed to provide an impartial picture of the industry to clients.

We have covered the key market players in different geographies, and provided in the report a look at their activities, recent developments and key biosimilar products. We observed that players such as Sandoz/Novartis AG, Hospira and Teva are the global market leaders. Overall, the report aims at providing complete information about the biosimilar industry to clients who are planning to enter the biosimilars market.



More Biosimilars reports by RNCOS

Global Biosimilar Market Outlook 2018 by RNCOS
Global Biosimilar Market Outlook 2018 The global biosimilars market is at a crucial turning point, as biosimilars are gaining wide acceptance around the world, with ...
Global EPO Biosimilars Market Outlook 2018 by RNCOS
Global EPO Biosimilars Market Outlook 2018 The biosimilars industry has been growing stupendously across the globe for the past few years. Increasing healthcare costs, major ...
Human Growth Hormone Market Forecast to 2015 by RNCOS
Since the launch of human insulin product, protein-based therapies have found a prominent place in the biopharmaceutical industry. According to our new research report on ...
Erythropoietin Market Forecast to 2015 by RNCOS
In the biopharmaceutical industry, protein-based therapies have become one of the most effective clinical methods to treat a wide spectrum of diseases, ranging from cancer ...
See all reports like this >>

More Global Biosimilars reports

Global Biosimilars Market 2014-2018 by Infiniti Research Limited - TechNavio
Global Biosimilars Market 2014-2018TechNavio's analysts forecast the Global Biosimilars Market to grow at a CAGR of 27.58 percent over the period 2013-2018. One of the ...
Global Biosimilar Market Outlook 2018 by RNCOS
Global Biosimilar Market Outlook 2018 The global biosimilars market is at a crucial turning point, as biosimilars are gaining wide acceptance around the world, with ...
Global EPO Biosimilars Market Outlook 2018 by RNCOS
Global EPO Biosimilars Market Outlook 2018 The biosimilars industry has been growing stupendously across the globe for the past few years. Increasing healthcare costs, major ...
Analysis of the Global Biosimilars Market by Frost & Sullivan
Analysis of the Global Biosimilars Market Patent expirations of blockbuster biologics and a promising pipeline of biosimilars present positive opportunities for the global market. The ...
See all reports like this >>